In contrast, even slight anemia (nadir Hb < 11.0–11.5 g/dL) occurring during SAH is significantly associated with the risk of cerebral infarction and poor outcome at discharge and follow-up. This evidence concerns the gene GSTM1 and cerebral infarction.